AKR Corporindo (AKRA IJ) (Buy) - Stealth buyback amid short-term hiccups
AKRA delivered weak 9M24 result as expected, due to the weak trading business as
Plantation MW EP GH 620 30th Oct, 2024
Maintain Buy with a lower TP of IDR940/sh
Triple tailwind for the ceramic industry
The ceramic industry is currently benefiting from three significant tailwinds, in our view. Firstly, Indonesia has imposed anti-dumping duties on ceramic tile imports from 32 Chinese companies, with fees ranging from IDR 13,446 to IDR 94,544 per square meter. This regulation is to take effect at the end of October 2024 and will last for five years. Secondly, Indonesia’s government has extended a regulated gas price program of USD6/mmbtu, limiting the cost risk for the ceramic industry. Lastly, we expect higher government spending to improve grassroot demand in the ceramic industry, especially under the 3mn housing per year program by the new president, which we have yet to factor in as we await further details.
Performance to bottom out this year, setting the stage for margin expansion
We cut earnings by 45% for FY24F considering lower utilization and sales vol (see Fig. 7). Despite this, we think this is already priced in, and we expect ARNA to have a CAGR earnings of 15% over the next 3 years supported by: 1) ASP improvement due to the recent anti-dumping tariffs; 2) a recovery in sales volume, and 3) an increasing share of higher-margin white body products. We expect the white body product mix to grow from 12% of total sales this year to 17% by 2026F (Fig. 2), further supporting margin improvement. Additionally, increased plant utilization should to lift ARNA’s GPM from 34% in FY24F year to 36% in 2025F, with long-term margin likely to approach 2022 levels of 38-40%.
Maintain Buy on ARNA with TP of IDR940, implying 23% upside
We maintain our Buy rating with a DCF-based TP of IDR940, assuming a WACC of 12% (previouslyy 10%). Our TP implies 13.8x/11.9x FY25F/FY26F P/E, at +1 stdv 5Y average P/E of 14x and is favorable relative to the industry average of 25x FY25F P/E (). The stock is trading at 11.2x FY25F P/E. ARNA’s prudent management and resilience in maintaining profitability amid challenging market conditions justify a premium valuation, in our view. Furthermore, the stock provides a 5.3% dividend yield for FY25F and a robust ROE of 24.6%, nearly double that of its peers. Risks to our call are: 1) sudden changes in government regulations (i.e. gas price and safeguard import duties), 2) fierce product competition, and 3) slower demand recovery.
Year-end 31 Dec | FY23 | FY24F | FY25F | FY26F | |||
Currency (IDR) | Actual | Old | New | Old | New | Old | New |
Revenue (bn) | 2,447 | 3,258 | 2,621 | 0 | 2,903 | 0 | 3,238 |
Reported net profit (bn) | 445 | 772 | 425 | 0 | 501 | 0 | 580 |
Normalised net profit (bn) | 445 | 772 | 425 | 0 | 501 | 0 | 580 |
FD normalised EPS | 60.66 | 105.11 | 57.86 | 68.18 | 79.05 | ||
FD norm. EPS growth (%) | -22.7 | 20.1 | -4.6 | 17.8 | 15.9 | ||
FD normalised P/E (x) | 12.6 | – | 13.2 | – | 11.2 | – | 9.7 |
EV/EBITDA (x) | 7.9 | – | 7.8 | – | 6.7 | – | 5.9 |
Price/book (x) | 3.1 | – | 2.9 | – | 2.6 | – | 2.4 |
Dividend yield (%) | 7.1 | – | 5.6 | – | 5.3 | – | 6.2 |
ROE (%) | 24.6 | 36.1 | 22.6 | 24.6 | 25.7 | ||
Net debt/equity (%) | net cash | net cash | net cash | net cash | net cash | ||
Income statement (IDRbn) | |||||||||||||||||||
Year-end 31 Dec | FY22 | FY23 | FY24F | FY25F | FY26F | ||||||||||||||
Revenue | 2,587 | 2,447 | 2,621 | 2,903 | 3,238 | ||||||||||||||
Cost of goods sold | -1,534 | -1,543 | -1,716 | -1,861 | -2,048 | ||||||||||||||
Gross profit | 1,053 | 904 | 905 | 1,042 | 1,190 | ||||||||||||||
SG&A | -310 | -341 | -354 | -392 | -437 | ||||||||||||||
Employee share expense | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Operating profit | 742 | 563 | 551 | 650 | 753 | ||||||||||||||
EBITDA | 839 | 676 | 679 | 787 | 909 | ||||||||||||||
Depreciation | -96 | -113 | -128 | -138 | -156 | ||||||||||||||
Amortisation | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
EBIT | 742 | 563 | 551 | 650 | 753 | ||||||||||||||
Net interest expense | -8 | -11 | -15 | -15 | -15 | ||||||||||||||
Associates & JCEs | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Other income | 11 | 23 | 13 | 12 | 12 | ||||||||||||||
Earnings before tax | 746 | 576 | 549 | 647 | 750 | ||||||||||||||
Income tax | -165 | -127 | -121 | -142 | -165 | ||||||||||||||
Net profit after tax | 582 | 449 | 428 | 505 | 585 | ||||||||||||||
Minority interests | -5 | -4 | -4 | -4 | -5 | ||||||||||||||
Other items | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Preferred dividends | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Normalised NPAT | 576 | 445 | 425 | 501 | 580 | ||||||||||||||
Extraordinary items | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Reported NPAT | 576 | 445 | 425 | 501 | 580 | ||||||||||||||
Dividends | -329 | -401 | -312 | -297 | -350 | ||||||||||||||
Transfer to reserves | 248 | 44 | 113 | 203 | 230 | ||||||||||||||
Valuations and ratios | |||||||||||||||||||
Reported P/E (x) | 9.7 | 12.6 | 13.2 | 11.2 | 9.7 | ||||||||||||||
Normalised P/E (x) | 9.7 | 12.6 | 13.2 | 11.2 | 9.7 | ||||||||||||||
FD normalised P/E (x) | 9.7 | 12.6 | 13.2 | 11.2 | 9.7 | ||||||||||||||
Dividend yield (%) | 5.8 | 7.1 | 5.6 | 5.3 | 6.2 | ||||||||||||||
Price/cashflow (x) | 14.2 | 10.4 | 8.9 | 9.8 | 8.9 | ||||||||||||||
Price/book (x) | 3.1 | 3.1 | 2.9 | 2.6 | 2.4 | ||||||||||||||
EV/EBITDA (x) | 6.3 | 7.9 | 7.8 | 6.7 | 5.9 | ||||||||||||||
EV/EBIT (x) | 7.1 | 9.4 | 9.6 | 8.1 | 7.1 | ||||||||||||||
Gross margin (%) | 40.7 | 36.9 | 34.5 | 35.9 | 36.8 | ||||||||||||||
EBITDA margin (%) | 32.4 | 27.6 | 25.9 | 27.1 | 28.1 | ||||||||||||||
EBIT margin (%) | 28.7 | 23.0 | 21.0 | 22.4 | 23.3 | ||||||||||||||
Net margin (%) | 22.3 | 18.2 | 16.2 | 17.2 | 17.9 | ||||||||||||||
Effective tax rate (%) | 22.1 | 22.0 | 22.0 | 22.0 | 22.0 | ||||||||||||||
Dividend payout (%) | 57.0 | 90.1 | 73.4 | 59.4 | 60.4 | ||||||||||||||
ROE (%) | 34.4 | 24.6 | 22.6 | 24.6 | 25.7 | ||||||||||||||
ROA (pretax %) | 39.3 | 26.1 | 24.5 | 26.8 | 27.6 | ||||||||||||||
Growth (%) | |||||||||||||||||||
Revenue | 1.2 | -5.4 | 7.1 | 10.8 | 11.5 | ||||||||||||||
EBITDA | 19.7 | -19.4 | 0.4 | 16.0 | 15.5 | ||||||||||||||
Normalised EPS | 22.0 | -22.7 | -4.6 | 17.8 | 15.9 | ||||||||||||||
Normalised FDEPS | 22.0 | -22.7 | -4.6 | 17.8 | 15.9 | ||||||||||||||
Source: Company data, Verdhana estimates |
Cashflow statement (IDRbn) | |||||||||||||||||||
Year-end 31 Dec | FY22 | FY23 | FY24F | FY25F | FY26F | ||||||||||||||
EBITDA | 839 | 676 | 679 | 787 | 909 | ||||||||||||||
Change in working capital | -264 | -64 | 75 | -71 | -113 | ||||||||||||||
Other operating cashflow | -178 | -72 | -121 | -141 | -163 | ||||||||||||||
Cashflow from operations | 397 | 539 | 633 | 575 | 633 | ||||||||||||||
Capital expenditure | -269 | -173 | -275 | -275 | -375 | ||||||||||||||
Free cashflow | 127 | 366 | 358 | 300 | 258 | ||||||||||||||
Reduction in investments | 0 | 0 | 0 | 0 | |||||||||||||||
Net acquisitions | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Dec in other LT assets | 0 | 0 | 0 | 0 | |||||||||||||||
Inc in other LT liabilities | 0 | 0 | 0 | 0 | |||||||||||||||
Adjustments | -6 | -1 | 0 | 0 | 0 | ||||||||||||||
CF after investing acts | 121 | 365 | 358 | 300 | 258 | ||||||||||||||
Cash dividends | 8 | -2 | 0 | 0 | 0 | ||||||||||||||
Equity issue | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Debt issue | 31 | 61 | 0 | 0 | 0 | ||||||||||||||
Convertible debt issue | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Others | -324 | -422 | -311 | -296 | -349 | ||||||||||||||
CF from financial acts | -286 | -363 | -311 | -296 | -349 | ||||||||||||||
Net cashflow | -164 | 2 | 48 | 4 | -91 | ||||||||||||||
Beginning cash | 603 | 438 | 441 | 488 | 493 | ||||||||||||||
Ending cash | 438 | 441 | 488 | 493 | 402 | ||||||||||||||
Ending net debt | -388 | -330 | -378 | -382 | -291 | ||||||||||||||
Balance sheet (IDRbn) | |||||||||||||||||||
As at 31 Dec | FY22 | FY23 | FY24F | FY25F | FY26F | ||||||||||||||
Cash & equivalents | 438 | 441 | 488 | 493 | 402 | ||||||||||||||
Marketable securities | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Accounts receivable | 734 | 856 | 830 | 967 | 1,052 | ||||||||||||||
Inventories | 258 | 255 | 259 | 204 | 267 | ||||||||||||||
Other current assets | 172 | 23 | 25 | 27 | 31 | ||||||||||||||
Total current assets | 1,602 | 1,574 | 1,602 | 1,691 | 1,751 | ||||||||||||||
LT investments | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Fixed assets | 945 | 1,007 | 1,154 | 1,292 | 1,510 | ||||||||||||||
Goodwill | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Other intangible assets | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Other LT assets | 32 | 40 | 42 | 47 | 52 | ||||||||||||||
Total assets | 2,579 | 2,620 | 2,798 | 3,030 | 3,314 | ||||||||||||||
Short-term debt | 50 | 111 | 111 | 111 | 111 | ||||||||||||||
Accounts payable | 312 | 306 | 345 | 331 | 337 | ||||||||||||||
Other current liabilities | 324 | 235 | 252 | 279 | 311 | ||||||||||||||
Total current liabilities | 686 | 652 | 708 | 721 | 759 | ||||||||||||||
Long-term debt | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Convertible debt | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Other LT liabilities | 60 | 113 | 121 | 135 | 150 | ||||||||||||||
Total liabilities | 746 | 765 | 829 | 856 | 909 | ||||||||||||||
Minority interest | 29 | 32 | 33 | 34 | 35 | ||||||||||||||
Preferred stock | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Common stock | 98 | 98 | 98 | 98 | 98 | ||||||||||||||
Retained earnings | 1,733 | 1,776 | 1,889 | 2,092 | 2,322 | ||||||||||||||
Proposed dividends | 0 | 0 | 0 | 0 | 0 | ||||||||||||||
Other equity and reserves | -27 | -50 | -50 | -50 | -50 | ||||||||||||||
Total shareholders' equity | 1,804 | 1,824 | 1,937 | 2,140 | 2,370 | ||||||||||||||
Total equity & liabilities | 2,579 | 2,620 | 2,798 | 3,030 | 3,314 | ||||||||||||||
Liquidity (x) | |||||||||||||||||||
Current ratio | 2.34 | 2.41 | 2.26 | 2.34 | 2.31 | ||||||||||||||
Interest cover | 96.9 | 51.9 | 36.9 | 43.5 | 50.4 | ||||||||||||||
Leverage | |||||||||||||||||||
Net debt/EBITDA (x) | net cash | net cash | net cash | net cash | net cash | ||||||||||||||
Net debt/equity (%) | net cash | net cash | net cash | net cash | net cash | ||||||||||||||
Per share | |||||||||||||||||||
Reported EPS (IDR) | 78.49 | 60.66 | 57.86 | 68.18 | 79.05 | ||||||||||||||
Norm EPS (IDR) | 78.49 | 60.66 | 57.86 | 68.18 | 79.05 | ||||||||||||||
FD norm EPS (IDR) | 78.49 | 60.66 | 57.86 | 68.18 | 79.05 | ||||||||||||||
BVPS (IDR) | 245.75 | 248.40 | 263.80 | 291.48 | 322.80 | ||||||||||||||
DPS (IDR) | 44.75 | 54.65 | 42.46 | 40.50 | 47.73 | ||||||||||||||
Activity (days) | |||||||||||||||||||
Days receivable | 99.9 | 118.5 | 117.7 | 113.0 | 113.8 | ||||||||||||||
Days inventory | 49.5 | 60.6 | 54.7 | 45.4 | 41.9 | ||||||||||||||
Days payable | 70.9 | 73.1 | 69.3 | 66.3 | 59.5 | ||||||||||||||
Cash cycle | 78.5 | 106.0 | 103.1 | 92.0 | 96.2 | ||||||||||||||
Source: Company data, Verdhana estimates |
Revise earnings guidance on the back of lower sales and prices
We cut earnings by 45%/30% for FY24F/FY25F to factor in possible lower utilization, a result of likely lower sales volumes. We expect sales volumes to decline 13%/9% in FY24F/FY25F to 66.3/71.7 mn sqm (vs previously at 76.0/79.2 mn sqm). Furthermore, we expect ARNA to have a lower ASP resulting from increased competition with Chinese imported brands. As opposed to our previous blended ASP assumption of IDR42,846- IDR45,456 per sqm for FY24F-FY26F, we now see a significantly lower blended ASP range of IDR39,519-IDR41,711 for the same period. Overall, more challenging market conditions will result in lower utilization and selling power for ARNA, and we revise FY24F/25F earnings estimates to USD425/USD501.
INVESTMENT RATINGS
A rating of ‘Buy’, indicates that the analyst expects the stock to outperform the Benchmark over the next 12 months. A rating of ‘Neutral’, indicates that the analyst expects the stock to perform in line with the Benchmark over the next 12 months. A rating of ‘Reduce’, indicates that the analyst expects the stock to underperform the Benchmark over the next 12 months. A rating of ‘Suspended’, indicates that the rating, target price, and estimates have been suspended temporarily to comply with applicable regulations and/or firm policies. Securities and/or companies that are labelled as ‘Not Rated’ or ‘No Rating’ are not in regular research coverage. Benchmark is Indonesia Composite Index (‘IDX Composite’). A ‘Target Price’, if discussed, indicates the analyst’s forecast for the share price with a 12-month time horizon, reflecting in part of the analyst’s estimates for the company’s earnings, and may be impeded by general market and macroeconomic trends, and by other risks related to the company or the market in general.
GENERAL DISCLOSURE/DISCLAIMER
This report is prepared by PT Verdhana Sekuritas Indonesia (“PTVSI”) a securities company registered in Indonesia, supervised by Indonesia Financial Services Authority (OJK) and a member of the Indonesia Stock Exchange (IDX).
This report is intended for client of PTVSI only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii) redistributed without the prior written consent of PTVSI.
The research set out in this report is based on information obtained from sources believed to be reliable, but PTVSI do not make any representation or warranty as to its accuracy, completeness or correctness. The information in this report is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed and it may not contain all material information concerning the company (or companies) referred to in this report. Any information, valuations, opinions, estimates, forecasts, ratings or targets herein constitutes a judgment as of the date of this report is published, and there is no assurance that future results or events will be consistent.
This report is not to be construed as an offer or a solicitation of an offer to buy or sell any securities or financial products. PTVSI and its associates, its directors, and/or its employees may from time to time have interests in the securities mentioned in this report or it may or will engage in any securities transaction or other capital market services for the company (companies) mentioned herein.
ANALYST CERTIFICATION
The research analyst primarily responsible for the content of this report and certifies that the views about the companies including their securities expressed in this report accurately reflect his/her personal views. The analyst also certifies that no part of his/her compensation was, is, or will be, directly, or indirectly, related to specific recommendations or views expressed in this report.
RESTRICTIONS ON DISTRIBUTION
By accepting this report, the recipient hereof represents and warrants that you are entitled to receive such report in accordance with the restrictions and agrees to be bound by the limitations contained herein. Neither this report nor any copy hereof may be distributed except in compliance with applicable Indonesian capital market laws and regulations.
Rating Remains | Buy |
Target price Reduced from IDR 1,300 | IDR 940 |
Closing price 29 October 2024 | IDR 765 |
Implied upside | +22.9% |
Market Cap (USD mn) | 356.5 |
ADT (USD mn) | 0.2 |
Source: LSEG, Verdhana
M cap (USDmn) | 356.5 |
Free float (%) | 47.6 |
3-mth ADT (USDmn) | 0.2 |
(%) | 1M | 3M | 12M |
Absolute (IDR) | 12.5 | 8.5 | 15.0 |
Absolute (USD) | 8.0 | 12.1 | 16.4 |
Rel to Jakarta Stock Exchange Composite Index | 13.7 | 4.2 | 2.5 |
Michael Wildon (michael.wildon@verdhana.id)
Edward Prima (edward.prima@verdhana.id)
Gerald Hugo (gerald.hugo@verdhana.id)